Published online 1 September 2005
Article |
Biased exon/intron distribution of cryptic and de novo 3' splice sites
ová
echovsk
*University of Southampton School of Medicine, Division of Human Genetics Southampton SO16 6YD, UK
*To whom correspondence should be addressed. Tel: +44 2380 796425; Fax: +44 2380 794264; Email: igvo{at}soton.ac.uk
Received June 6, 2005. Revised July 25, 2005. Accepted August 16, 2005.
We compiled sequences of previously published aberrant 3' splice sites (3'ss) that were generated by mutations in human disease genes. Cryptic 3'ss, defined here as those resulting from a mutation of the 3'YAG consensus, were more frequent in exons than in introns. They clustered in 
20 nt region adjacent to authentic 3'ss, suggesting that their under-representation in introns is due to a depletion of AG dinucleotides in the polypyrimidine tract (PPT). In contrast, most aberrant 3'ss that were induced by mutations outside the 3'YAG consensus (designated ‘de novo’) were in introns. The activation of intronic de novo 3'ss was largely due to AG-creating mutations in the PPT. In contrast, exonic de novo 3'ss were more often induced by mutations improving the PPT, branchpoint sequence (BPS) or distant auxiliary signals, rather than by direct AG creation. The Shapiro–Senapathy matrix scores had a good prognostic value for cryptic, but not de novo 3'ss. Finally, AG-creating mutations in the PPT that produced aberrant 3'ss upstream of the predicted BPS in vivo shared a similar ‘BPS-new AG’ distance. Reduction of this distance and/or the strength of the new AG PPT in splicing reporter pre-mRNAs improved utilization of authentic 3'ss, suggesting that AG-creating mutations that are located closer to the BPS and are preceded by weaker PPT may result in less severe splicing defects.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Kralovicova and I. Vorechovsky Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition Nucleic Acids Res., October 8, 2007; 35(19): 6399 - 6413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Akerman and Y. Mandel-Gutfreund Does distance matter? Variations in alternative 3' splicing regulation Nucleic Acids Res., August 17, 2007; (2007) gkm603v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Chivers, J. Kralovicova, M. Romano, M. Baralle, A. R. Krainer, and I. Vorechovsky Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization Nucleic Acids Res., July 26, 2007; 35(13): 4250 - 4263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vorechovsky Aberrant 3' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization Nucleic Acids Res., September 15, 2006; (2006) gkl535v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Buratti, M. Baralle, and F. E. Baralle Defective splicing, disease and therapy: searching for master checkpoints in exon definition Nucleic Acids Res., July 19, 2006; 34(12): 3494 - 3510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kralovicova and I. Vorechovsky Position-Dependent Repression and Promotion of DQB1 Intron 3 Splicing by GGGG Motifs J. Immunol., February 15, 2006; 176(4): 2381 - 2388. [Abstract] [Full Text] [PDF]
|
|